$SWTX short stroke champion strong revenue NASDAQ:SWTX strong revenue seeing positive reaction. Bouncing off yesterday's high.
SWTX trade ideas
SWTX (SpringWorks Therapeutics) - Bullish end to QuarterSPRINGWORKS THERAPEUTICS INC.
SpringWorks Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on developing life-changing medicines for patients with severe rare diseases and cancer. The company's product pipeline consists of Nirogacestat and Mirdametinib which are in clinical stage. SpringWorks Therapeutics Inc. is based in Stamford, United States.
Analysis/Commentary
New business, so lots of unknowns, but potential to the upside
Based on the study of the previous quarterly earnings reports and subsequent price moves:
- Current quarter has given price move below LOW point
- Buy opportunity in place
- Expectation for the price to move back to LOW or MID point
- Trailing stop-loss on price above LOW point
GOOD LUCK.
DO YOUR OWN RESEARCH!
SpringWorks $50 BullDouble dip, butterflies and new support suggest this could move towards $50. This is also supported by bullish broker sentiment.
Springworks Therapeutics, on Breakout alert $swtxMassive breakout potential setting up.
Short interest 7%
Springworks Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It identifies pathways for drug development for patients with severe rare diseases and cancer. The firm's products include Nirogacestat, Mirdametinib and BGB-3245. The company was founded in August 2017 and is headquartered in Stamford, CT.
